16th November 2020  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 17 Nov 2020


Soon after the Pfizer-BioNTech SARS-CoV-2 vaccine’s promising results were shared with the world, the COVID-19 pandemic took another turn for the worse, with the emergence of a new strain of the virus on mink farms in the EU with potential to make the vaccine ineffective.

The new variant of the strain contained a mutation on the spike protein; the viral antigen that most vaccines and antigen tests target. Swift action to close the farms and cull the animals may have contained that strain, for the foreseeable future, but it highlighted how precarious the SARS-CoV-2 situation is.

Despite the effectiveness vaccines have shown in studies, their storage requirements and deployment to high-risk people in countries around the world is a logistics nightmare.

Doses of the vaccine are still limited, and to compensate, mass screening of individuals by rapid test methods in Slovakia and the city of Liverpool (UK) has led by example with other countries are following suit, i.e. Canada.

It’s planning on being a busy time of year for everyone involved, so best to keep updated with the latest developments on rapid tests by following this page in each week’s newsletter.

COVID-19 Rapid Test Centres at German Airports Adopt Fully-Automated Workflow

COVID-19 Rapid Test Centres at German Airports Adopt Fully-Automated Workflow

Through a partnership with Centogene and Fujirebio, Lufthansa airports in Germany are expanding its antigen testing program for its passengers. Fujirebio will provide Centogene labs with a steady supply of its Lumipulse G SARS-CoV-2 Ag to run on the fully-automated LUMIPULSE G1200 system.
Find Out More

 

Saliva Collection Device Validated for FDA-EUA High-Throughput SARS-CoV-2 Testing

Saliva Collection Device Vaildated for FDA-EUA High-Throughput SARS-CoV-2 Testing

Precision Genomics has validated the new GeneFiX™ Saliva RNA Collection Device from Isohelix. It is now its preferred method for saliva collection as part of its FDA-EUA SARS-CoV-2 testing portfolio. 
Find Out More

 

New SARS-CoV-2 Rapid Antigen and Near-Patient Test Kit Buyer's Guide

New SARS-CoV-2 Rapid Antigen and Near-Patient Test Kit Buyer's Guide

This buyers guide summarizes the range of COVID-19 rapid tests available on the world market for near-patient, screening and serial testing at workplaces, airports and schools. It also gives details of each supplier and provides a means to contact them. ​
Find Out More

 

New ELISA Test for Vaccine Research Quantifies IgG Antibody to SARS-CoV-2 Spike Protein

New ELISA Test for Vaccine Research Quantifies IgG Antibody to SARS-CoV-2 Spike Protein

EUROIMMUN has launched the Anti-SARS-CoV-2 QuantiVac™ ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is CE-marked, and the company plans to file for US FDA-EUA.
Find Out More

 

Portable Digital SARS-CoV-2 Antigen Test Analyzes Over 30 Samples Per Hour

Portable Digital SARS-CoV-2 Antigen Test Analyzes Over 30 Samples Per Hour

QIAGEN has begun distributing its QIAreach™ SARS-CoV-2 Antigen Test for use on digital eHub and eStick system developed by Ellume. The portable device can give a positive result in as little as 2 minutes and a negative in 15 minutes.
Find Out More


    

Tags:

Date Published: 16th November 2020


View full company details




rapidmicrobiology.com

Address:

Cork

Ireland

Tel: +[353] 23 88 31884

Email Supplier

View full company details


Related news from rapidmicrobiology.com